Top 5 Takeaways Immunocompromised patients represented a significant portion of COVID-19 hospitalizations. Accounting for 12.2% of adult COVID-19 hospitalizations across 10 states, immunocompromised patients had increased odds of ICU admission
Tag: COVID
Top 5 Takeaways Case Counts Fluctuated During the Pandemic: Coccidioidomycosis and histoplasmosis case counts dropped in 2020 compared to 2019, but saw an increase in 2021. A notable high blastomycosis
Top 5 Takeaways Reduced Reactions Post-Booster: Immunocompromised individuals aged ≥12 years reported fewer local and systemic reactions after the fourth dose (mRNA booster) compared to after the third dose of
Top 5 Takeaways Significant Decrease in HIV Testing and Case Identification: The first months of the COVID-19 pandemic saw a 40.1% decrease in HIV testing and a 29.4% decrease in
Top 5 Takeaways High Prevalence of Mental Health Conditions: Among 26,069 surveyed STLT public health workers in 2022, notable percentages reported symptoms of depression (27.7%), anxiety (27.9%), PTSD (28.4%), and
Top 5 Takeaways Vaccine Effectiveness (VE) varies with dose number and Omicron sublineage. VE was generally lower during the Omicron BA.2/BA.2.12.1 period compared to the BA.1 period. A third dose
Top 5 Takeaways Reduction in Adverse Reactions: Among adults aged ≥50 years, adverse reactions were less frequent following a second mRNA COVID-19 booster dose compared to the first booster dose.
Top 5 Takeaways Continued incidence but decreasing trend of MIS-C: While the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) has decreased significantly from its peak early in the COVID-19
Top 5 Takeaways Decreased adverse reactions after second booster: Among individuals ≥50 years who received homologous mRNA COVID-19 vaccination, both injection site and systemic reactions were reported less frequently after
Top 5 Takeaways Emergency Use Authorization Granted: The FDA issued an EUA for the Novavax COVID-19 vaccine on July 13, 2022, for primary immunization in adults aged ≥18 years. ACIP’s